Jocelyn Mora
7 Papers
Jocelyn Mora is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
Steven Y. C. Tong,Jocelyn Mora,Asha C. Bowen,Matthew P. Cheng,Nick Daneman,Anna Goodman,George S. Heriot,Todd C. Lee,Roger J. Lewis,David C. Lye,Robert K Mahar,Julie A. Marsh,Anna McGlothlin,Zoe McQuilten,Susan C. Morpeth,David A. Patterson,David Price,Jason A. Roberts,James O. Robinson,S. J. van Hal,Genevieve Walls,Steve Webb,Lyn Whiteway,Dafna Yahav,Joshua S. Davis +24 more
TL;DR: The rationale and framework for an adaptive platform trial applied to SAB infections, and the design features of the Staphylococcus aureus Network Adaptive Platform (SNAP) trial that will enable multiple questions to be answered as efficiently as possible are provided.
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
Dana de Kretser,Jocelyn Mora,Max Bloomfield,Anita Campbell,Matthew P. Cheng,Stephen Guy,Marjolein Hensgens,Shirin Kalimuddin,Todd C. Lee,Amy Legg,Robert K. Mahar,Michael Marks,Julie A. Marsh,Anna McGlothlin,Susan C. Morpeth,Archana Sud,Jaap ten Oever,Dafna Yahav,Steven Y C Tong,Joshua S. Davis,Genevieve Walls,Anna L Goodman,Marc J. Bonten +22 more
TL;DR: The early oral switch (EOS) domain of the S. aureus Network Adaptive Platform (SNAP) trial will assess early switch to oral antibiotics compared with continued IV treatment in clinically stable patients with SAB.
6
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus.
Andrew Henderson,Matthew P. Cheng,Ka Lip Chew,Geoffrey W. Coombs,Joshua S. Davis,Jennifer Grant,Daniel B. Gregson,Stefano Giulieri,Benjamin P Howden,Todd C. Lee,Vi Nguyen,Jocelyn Mora,Susan C. Morpeth,James O. Robinson,Steven Y. C. Tong,S. J. van Hal +15 more
TL;DR: In this paper , the authors used blaZ PCR as the gold standard to assess susceptibility testing performance of CLSI (P10 disc) and EUCAST (P1 disc) methods.
1
Exploratory Correlation of The Human Structural Connectome with Non-MRI Variables
TL;DR: In this article , Zhang et al. used diffusion-MRI data to explore structural connections between 85 brain regions with non-MRI variables, while stringently correcting the significance values for multiple testing and ruling out spurious correlations via careful visual inspection.
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial
Robert K. Mahar,Anna McGlothlin,M. Dymock,Lauren A Barina,Marc Bonten,Asha C Bowen,Matthew Cheng,Nick Daneman,A. Goodman,Todd C. Lee,Roger J Lewis,Thomas Lumley,Alistair R D McLean,Zoe K McQuilten,Jocelyn Mora,David L Paterson,David J. Price,Jason Roberts,Tom Snelling,Jonas Tverring,Steven A. Webb,Dafna Yahav,Joshua S Davis,Steven Y C Tong,Julie A. Marsh,Tom Boyles,Catherine Cosgrove,George S Heriot,M. Hensgens,D. Lye,S. Morpeth,Owen Robinson,Hiroki Saito,Matthew Scarborough,S. J. van Hal,Genevieve Walls,Lynda Whiteway +36 more
TL;DR: This study outlines a statistical documentation framework for multi-disease, multi-domain platform trials, using the Staphylococcus aureus Network Adaptive Platform trial as a case study, providing a template for researchers and reviewers to operationalize platform trials.